Related Experiment Video
Updated: Jun 27, 2026

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits
Published on: July 21, 2023
Antioxidant Nanotherapies for Intervertebral Disk Degeneration: Progress and Prospects
Yingzi Zhou1, Yihang Fan1, Yuxuan Hu1
1The First School of Clinical Medicine, Faculty of Medicine, Yangzhou University, Yangzhou 225009, China.
Antioxidant nanotherapies show promise for treating intervertebral disk degeneration (IVDD) and associated low back pain by targeting oxidative stress. These nanotechnology-based approaches scavenge reactive oxygen species (ROS) to restore cellular balance and halt degeneration.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Regenerative Medicine
Background:
- Intervertebral disk degeneration (IVDD) is a primary cause of low back pain (LBP), leading to significant public health and economic challenges.
- Oxidative stress, characterized by excessive reactive oxygen species (ROS) and disrupted redox homeostasis, drives IVDD progression through inflammation and cellular damage.
- Current therapies for IVDD primarily address macrostructural compression but fail to resolve underlying molecular dysregulation.
Purpose of the Study:
- To review and analyze antioxidant nanotherapies as a novel strategy for treating IVDD.
- To explore the mechanisms by which nanotherapies combat oxidative stress and protect intervertebral disc cells.
- To discuss the potential of nanotechnology in overcoming limitations of conventional IVDD treatments.
Main Methods:
- Analysis of four categories of antioxidant nanotherapies: inorganic nanozymes, bioactive nanomaterials, stimuli-responsive nanosystems, and nanocomposite scaffolds.
- Elaboration on the mechanisms of ROS scavenging, redox equilibrium restoration, and mitochondrial protection.
- Discussion of integrating biomimicry and responsiveness for multi-pathway ROS-scavenging nanosystems.
Main Results:
- Antioxidant nanotherapies effectively scavenge ROS, restore redox balance, protect mitochondrial function, and mitigate oxidative stress-induced degeneration in IVDD.
- Engineered composite nanosystems with biomimicry and responsiveness exhibit multi-pathway ROS-scavenging capabilities.
- Nanotechnology offers a promising avenue for arresting IVDD progression by targeting molecular mechanisms.
Conclusions:
- Nanotechnology-based antioxidant strategies represent a significant advancement in the therapeutic approach to IVDD.
- These nanotherapies hold potential for halting IVDD progression by addressing redox imbalances and oxidative stress.
- Key challenges in clinical translation of these nanotherapies require further investigation.
Related Concept Videos
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology
Herniated Intervertebral Disc l: Introduction